Article

Authors reply: an adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples.

University Federico II of Napoli, Department of Medical Oncology, Endocrinology and Oncology , Naples , Italy.
Expert Opinion on Pharmacotherapy (Impact Factor: 2.86). 03/2012; DOI: 10.1517/14656566.2012.668097
Source: PubMed
0 Bookmarks
 · 
58 Views